Pila Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	56	87	102	38	50	109
Market Cap Growth	-46.07%	-14.78%	167.21%	-23.60%	-54.48%	-
Enterprise Value	40	86	99	38	45	77
Last Close Price	1.33	2.06	3.75	1.60	3.10	6.64
PS Ratio	49.59	76.92	128.78	26.02	26.50	152.22
PB Ratio	3.78	5.86	19.33	5.72	5.23	3.61
P/TBV Ratio	3.78	5.86	24.31	8.45	7.91	4.05
EV/Sales Ratio	35.48	75.96	125.56	26.26	23.77	106.59
Net Debt / Equity Ratio	-1.07	-1.07	-0.93	-0.89	-0.76	-0.93
Net Debt / EBITDA Ratio	2.33	2.33	0.70	1.12	0.82	3.05
Asset Turnover	0.10	0.10	0.11	0.15	0.09	0.04
Quick Ratio	11.19	11.19	5.16	3.47	5.49	18.72
Current Ratio	11.26	11.26	5.21	3.48	5.59	18.81
Return on Equity (ROE)	-168.25%	-168.25%	-188.57%	-122.66%	-134.47%	-102.07%
Return on Assets (ROA)	-43.97%	-43.97%	-69.05%	-41.32%	-26.03%	-31.14%
Return on Capital Employed (ROCE)	-53.40%	-53.40%	-154.10%	-96.00%	-93.30%	-30.60%
Earnings Yield	-30.17%	-19.45%	-11.05%	-26.08%	-53.74%	-15.72%
Buyback Yield / Dilution	-35.92%	-35.92%	-20.66%	-22.29%	-31.86%	-30.89%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.